参考文献/References:
1 Vitaliani R, Mason W, Ances B, et al. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Annals of neurology, 2005, 58(4): 594-604.
2 Titulaer M J, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. The Lancet Neurology, 2013, 12(2): 157-165.
3 Dalmau J, T z n E, Wu H, et al. Paraneoplastic anti N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Annals of neurology, 2007, 61(1): 25-36.
4 Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. The Lancet Neurology, 2011, 10(1): 63-74.
5 Gable M S, Sheriff H, Dalmau J, et al. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clinical Infectious Diseases, 2012, 54(7): 899-904.
6 Irani S R, Bera K, Waters P, et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain, 2010, 133(6): 1655-1667.
7 Hughes E G, Peng X, Gleichman A J, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. The Journal of Neuroscience, 2010, 30(17): 5866-5875.
8 Planaguma J, Leypoldt F, Mannara F, et al. Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice. Brain, 2015,138(1):94-109.
9 Dulcey I, Céspedes M U, Ballesteros J L, et al. Necrotic mature ovarian teratoma associated with anti-N-methyl-D-aspartate receptor encephalitis. Pathology-Research and Practice, 2012, 208(8): 497-500.
10 Tanyi J L, Marsh E B, Dalmau J, et al. Reversible paraneoplastic encephalitis in three patients with ovarian neoplasms. Acta obstetricia et gynecologica Scandinavica, 2012, 91(5): 630-634.
11 Mann A P, Grebenciucova E, Lukas R V. Anti-N-methyl-D-aspartate-receptor encephalitis: diagnosis, optimal management, and challenges. Therapeutics and clinical risk management, 2014, 10: 517-525.
12 Tachibana N, Shirakawa T, Ishii K, et al. Expression of various glutamate receptors including N-methyl-D-aspartate receptor(NMDAR)in an ovarian teratoma removed from a young woman with anti-NMDAR encephalitis. Internal Medicine, 2010, 49(19): 2167-2173.
13 Tachibana N, Kinoshita M, Saito Y, et al. Identification of the N-Methyl-D-aspartate receptor(NMDAR)-related epitope, NR2B, in the normal human ovary: implication for the pathogenesis of anti-NMDAR encephalitis. The Tohoku journal of experimental medicine, 2013, 230(1): 13-16.
14 Tachibana N, Kinoshita M, Kametani F, et al. Expression of N-Methyl-D-Aspartate Receptor Subunits in the Bovine Ovum: Ova as a Potential Source of Autoantigens Causing Anti-NMDAR Encephalitis. The Tohoku journal of experimental medicine, 2015, 235(3): 223-231.
15 Masghati S, Nosratian M, Dorigo O. Anti-N-Methyl-Aspartate Receptor Encephalitis in Identical Twin Sisters: Role for Oophorectomy. Obstetrics & Gynecology, 2014, 123(2): 433-435.
16 Lamale-Smith L M, Moore G S, Guntupalli S R, et al. Maternal-Fetal Transfer of Anti N-Methyl-D-Aspartate Receptor Antibodies. Obstetrics & Gynecology, 2015, 125(5): 1056-1058.
17 Adang L A, Lynch D R, Panzer J A. Pediatric anti-NMDA receptor encephalitis is seasonal. Annals of clinical and translational neurology, 2014, 1(11): 921-925.
18 刘 磊, 宋兆慧, 郭 晶, 等. 国人45例抗 N-甲基-D-天冬氨酸受体脑炎病例分析. 中华神经科杂志, 2014, 47(7):474-524.
19 Venkatesan A, Benavides D R. Autoimmune Encephalitis and Its Relation to Infection. Current neurology and neuroscience reports, 2015, 15(3): 1-11.
20 Prüss H, Finke C, Höltje M, et al. N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Annals of neurology, 2012, 72(6): 902-911.
21 Leypoldt F, Titulaer M J, Aguilar E, et al. Herpes simplex virus 1 encephalitis can trigger anti-NMDA receptor encephalitis: Case report. Neurology, 2013, 81(18): 1637-1639.
22 Panzer J A, Gleichman A J, Lynch D R. Glutamatergic autoencephalitides: an emerging field. Journal of Neural Transmission, 2014, 121(8): 957-968.
23 Armangue T, Leypoldt F, M laga I, et al. Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Annals of neurology, 2014, 75(2): 317-323.
24 Hacohen Y, Deiva K, Pettingill P, et al. N-methyl-D-aspartate receptor antibodies in post herpes simplex virus encephalitis neurological relapse. Movement Disorders, 2014, 29(1): 90-96.
25 Ito Y, Abe T, Tomioka R, et al. Anti-NMDA receptor encephalitis during pregnancy. Rinsho Shinkeigaku, 2010, 50(2): 103-107.
26 Kumar M A, Jain A, Dechant V E, et al. Anti N-methyl-D-aspartate receptor encephalitis during pregnancy. Archives of neurology, 2010, 67(7): 884-887.
27 Magley J, Towner D, Tach V, et al. Pregnancy outcome in anti-N-methyl-D-aspartate receptor encephalitis. Obstetrics & Gynecology, 2012, 120: 480-483.
28 McCarthy A, Dineen J, McKenna P, et al. Anti-NMDA receptor encephalitis with associated catatonia during pregnancy. Journal of neurology, 2012, 259(12): 2632-2635.
29 Jagota P, Vincent A, Bhidayasiri R. Transplacental transfer of NMDA receptor antibodies in an infant with cortical dysplasia. Neurology, 2014, 82(18): 1662-1663.
30 Lamale-Smith L M, Moore G S, Guntupalli S R, et al. Maternal-Fetal Transfer of Anti N-Methyl-D-Aspartate Receptor Antibodies. Obstetrics & Gynecology, 2015, 125(5): 1056-1058.
31 Chan L W, Nilsson C, Schepel J, et al. A rare case of anti-N-methyl-D-aspartate receptor encephalitis during pregnancy. The New Zealand medical journal, 2014, 128(1411): 89-91.
32 Shahani L. Steroid unresponsive anti-NMDA receptor encephalitis during pregnancy successfully treated with plasmapheresis. BMJ case reports, 2015: bcr2014208823.
33 Prüss H, Dalmau J, Harms L, et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology, 2010, 75(19): 1735-1739.
34 Tuzun E, Erdag E, Durmus H, et al. Autoantibodies to neuronal surface antigens in thyroid antibody-positive and-negative limbic encephalitis. Neurology India, 2011, 59(1): 47.
35 Sartori S, Nosadini M, Cesaroni E, et al. Paediatric anti-N-methyl-d-aspartate receptor encephalitis: The first Italian multicenter case series. European Journal of Paediatric Neurology, 2015.
36 Lu J, Samson S, Kass J, et al. Acute psychosis in a pregnant patient with Graves' hyperthyroidism and anti-NMDA receptor encephalitis. BMJ case reports, 2015, 2015: bcr2014208052.
37 Suzuki H, Kitada M, Ueno S, et al. Anti-NMDAR encephalitis preceded by dura mater lesions. Neurol Sci 2013, 34(6): 1021-1022.
38 Peery H E, Day G S, Dunn S, et al. Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology. Autoimmunity reviews, 2012, 11(12): 863-872.
39 Lazar-Molnar E, Tebo A E. Autoimmune NMDA receptor encephalitis. Clinica chimica acta, 2015, 438: 90-97.
40 Liba Z, Sebronova V, Komarek V, et al. Prevalence and treatment of anti-NMDA receptor encephalitis. The Lancet Neurology, 2013, 12(5): 424-425.